High materiality8/10
Oric Pharmaceuticals initiated with an Outperform at Leerink
Why it may matterVerify against the original reporting
Clear upside potential reflected in favorable rating.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Leerink Partners initiates Oric Pharmaceuticals with an Outperform rating; PT $26 vs posted price $12.21.
- Leerink initiates Outperform; PT $26 vs price $12.21.
Key facts
- 01
Target: $26
- 02
Posted price: $12.21
- 03
Analyst firm: Leerink Partners
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.